Product NDC: | 63323-359 |
Proprietary Name: | Kanamycin |
Non Proprietary Name: | KANAMYCIN A SULFATE |
Active Ingredient(s): | 333 mg/mL & nbsp; KANAMYCIN A SULFATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-359 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065111 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030128 |
Package NDC: | 63323-359-03 |
Package Description: | 10 VIAL in 1 TRAY (63323-359-03) > 3 mL in 1 VIAL |
NDC Code | 63323-359-03 |
Proprietary Name | Kanamycin |
Package Description | 10 VIAL in 1 TRAY (63323-359-03) > 3 mL in 1 VIAL |
Product NDC | 63323-359 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | KANAMYCIN A SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20030128 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | KANAMYCIN A SULFATE |
Strength Number | 333 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |